Active Biotech AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 24, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	175	121	116	165	255	276
Market Cap Growth	84.79%	4.60%	-29.80%	-35.20%	-7.51%	0.37%
Enterprise Value	112	113	112	163	204	207
Last Close Price	0.07	0.05	0.09	0.16	0.31	0.39
PB Ratio	3.15	2.18	3.54	5.39	7.38	5.90
P/TBV Ratio	3.16	2.19	3.57	5.43	7.44	5.90
Debt / Equity Ratio	0.03	0.03	0.10	0.15	0.18	0.02
Net Debt / Equity Ratio	-1.14	-1.14	-0.74	-1.03	-1.04	-1.12
Net Debt / EBITDA Ratio	1.76	1.76	0.63	0.71	0.62	1.08
Quick Ratio	4.60	4.60	4.14	3.61	3.54	5.49
Current Ratio	4.67	4.67	4.40	3.73	3.66	5.64
Return on Equity (ROE)	-84.48%	-84.48%	-124.26%	-140.54%	-143.80%	-144.87%
Return on Assets (ROA)	-41.45%	-41.45%	-57.09%	-61.13%	-67.12%	-69.95%
Return on Capital Employed (ROCE)	-67.50%	-67.50%	-116.20%	-138.10%	-148.60%	-106.10%
Earnings Yield	-21.32%	-30.78%	-33.98%	-27.73%	-22.91%	-18.08%
Buyback Yield / Dilution	-220.46%	-220.46%	-54.84%	-16.21%	-9.23%	-26.87%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.